When Should You Use Stratified Randomization in Research?

When Is Ordinary Randomization Not Enough for Important Baseline Characteristics?

You are designing a randomized controlled trial involving participants with substantially different baseline characteristics. Some students enter with high prior achievement, while others require additional academic support. In a clinical trial, participants may differ in disease severity or treatment history.

Random assignment should distribute these characteristics between intervention groups in expectation, but it cannot guarantee balance in the particular sample recruited.

Would it be better to classify participants into relevant categories before randomization and allocate treatments separately within those categories? If so, which characteristics deserve stratification, and how many should be included?

The decision matters because stratification can improve balance on selected prognostic variables, but unnecessary or poorly implemented stratification may introduce complexity without delivering meaningful benefits.

Stratify When Important Prognostic Factors Justify Restricted Allocation

How to Determine Whether Stratification Is Worthwhile

What Problem Does Stratified Randomization Address?

Stratified randomization aims to improve treatment allocation balance on selected characteristics known before randomization.

Suppose baseline achievement strongly predicts final writing performance. In a small trial, unrestricted randomization could place disproportionately more high-achieving students in one treatment group.

That imbalance would arise by chance if randomization were implemented correctly, but it could affect the precision and interpretation of the estimated intervention effect.

Stratification allows the researchers to organize treatment allocation according to baseline achievement categories, reducing the likelihood of substantial numerical imbalance within those categories when an appropriate restricted randomization method is used.

The purpose is not to eliminate confounding through statistical matching or to make participants identical. Proper randomization already addresses systematic baseline confounding in expectation. Stratification adds a design-based mechanism for improving balance on selected measured factors.

Why Are Prognostic Factors Especially Important?

A prognostic factor is a baseline characteristic associated with the outcome, regardless of the treatment received.

Examples may include baseline disease severity in clinical research, prior academic achievement in educational research, or an established risk score in a prevention trial.

When a factor strongly predicts the primary outcome, imbalance between treatment groups can contribute to outcome variability and reduce the precision of an unadjusted treatment comparison.

Stratifying on such a factor may improve balance, while appropriate covariate adjustment can further improve precision.

However, the benefit depends on the strength of the prognostic relationship, the allocation method, and the analysis. A variable should not be selected merely because it is easy to collect or commonly reported in baseline tables.

Researchers should prioritize characteristics supported by previous evidence, substantive theory, or strong methodological justification.

When Is Stratification Particularly Useful in Small Trials?

Smaller trials are more susceptible to noticeable chance imbalances because relatively few randomized participants contribute to each treatment group.

For example, a trial with 40 participants might include 12 individuals with a particularly severe baseline condition. Under unrestricted randomization, those 12 individuals could be distributed unevenly between treatments.

If severity strongly predicts the primary outcome, the imbalance could make treatment comparisons less precise.

Stratified randomization may reduce this risk by allocating treatments separately within severity categories.

Nevertheless, stratification is not automatically beneficial simply because a trial is small. If too many categories are introduced, individual strata may contain very few participants, undermining the intended balance.

Researchers should consider the expected number of participants in each stratum, not merely the overall sample size.

Should Multicenter Trials Stratify by Study Site?

Study site is a common stratification factor because institutions may differ in participant characteristics, treatment delivery, routine care, or outcome levels.

In an educational trial, universities may differ in admission profiles, assessment practices, instructional resources, and student support systems.

Stratifying by site can help maintain treatment allocation balance within participating institutions, particularly when recruitment rates vary.

However, site stratification is not automatically necessary or feasible. Trials involving many sites with very few participants per site may generate numerous incomplete blocks or sparse strata.

In such settings, alternative allocation methods or suitable analysis adjustments may be preferable.

Researchers should also distinguish individual randomization stratified by site from cluster randomization in which entire sites are assigned to treatment conditions.

These designs answer different allocation questions. If a whole school is randomized, individual students within that school are not separately randomized merely because school characteristics were considered during allocation.

Should You Stratify by Variables That Predict Treatment Response?

A treatment-effect modifier is a characteristic associated with differences in the effect of an intervention across participant subgroups.

Effect modifiers and prognostic factors are not necessarily the same. A characteristic may predict the outcome strongly without modifying treatment effectiveness, or it may modify the treatment effect without being strongly prognostic overall.

Stratification on a plausible effect modifier may be justified when the trial has an important prespecified objective involving that characteristic.

For example, researchers might hypothesize that an AI tutoring intervention operates differently among students with low and high prior digital literacy.

Stratifying by digital literacy could improve treatment allocation balance within the relevant categories, but it would not automatically provide adequate statistical power to estimate subgroup-specific treatment effects or test an interaction.

If effect modification is a primary objective, the sample-size calculation and analysis should explicitly address that objective.

How Do You Select Appropriate Stratification Variables?

A useful stratification variable should be scientifically relevant, measured before allocation, and available reliably when the participant is randomized.

It should also be possible to define its categories consistently across recruitment sites and personnel.

Researchers should generally avoid variables whose values are uncertain, frequently missing, or determined after treatment assignment.

For example, baseline achievement may be appropriate when measured through a standardized assessment completed before randomization. Subsequent intervention engagement would not be appropriate as a baseline stratification variable because it occurs after allocation.

Continuous characteristics may need to be categorized for conventional stratified randomization. However, categorization loses information and can create artificial boundaries between participants with similar values.

When a continuous baseline variable is strongly prognostic, researchers should consider whether stratification is necessary in addition to covariate adjustment using the continuous measurement.

How Many Stratification Variables Should You Include?

There is no universal maximum number of stratification variables, but the number of possible strata increases as categorical factors are combined.

For conventional cross-classified stratification, the number of possible strata is the product of the numbers of categories across the selected variables.

The calculation illustrates why adding variables can become problematic. Some strata may contain many participants while others contain few or none.

With permuted-block allocation, sparsely populated strata may end recruitment with incomplete blocks and substantial overall imbalance.

Researchers should therefore prioritize the most important factors and examine expected enrollment patterns before implementing the allocation procedure.

The more detailed decision about how many stratification variables are too many depends on sample size, categories, recruitment patterns, and the allocation method.

How Does Stratified Permuted-Block Randomization Work?

Conventional stratified permuted-block randomization begins by assigning each eligible participant to a predefined stratum using baseline information.

A separate randomization sequence is then maintained for each stratum. Within each sequence, permuted blocks are used to control treatment allocation numbers.

For example, a trial may define two baseline achievement strata: lower achievement and higher achievement.

Each stratum receives an independently generated blocked allocation sequence. When a student enters the trial, the appropriate stratum is identified and the next concealed assignment from that stratum's sequence is used.

This arrangement can maintain approximate treatment balance within each achievement category.

However, if the block structure is predictable or the allocation sequence is accessible to recruiters, selection bias may arise. Stratification does not replace the need for proper allocation concealment.

How Does Stratification Differ From Simple and Block Randomization?

The distinction is best understood by identifying which allocation property each procedure targets.

The broader comparison of simple, block, and stratified randomization clarifies why these approaches should not be treated as interchangeable.

When Might Minimization Be Preferable?

Minimization is a covariate-adaptive allocation method that seeks to reduce imbalance across selected baseline characteristics as participants enter the trial.

Rather than creating a separate allocation sequence for every possible combination of characteristics, minimization evaluates how a new assignment would affect a specified imbalance criterion.

A random component can be included so that assignment remains probabilistic rather than completely deterministic.

This approach may be useful when several important factors need consideration but conventional stratification would produce too many sparsely populated strata.

Nevertheless, minimization requires a properly implemented algorithm, protected allocation procedures, and an analysis plan that reflects the design.

It should not be selected merely because it appears more sophisticated than conventional stratification.

Should Stratification Variables Be Included in the Analysis?

Generally, yes. Statistical analysis should ordinarily account for variables used in stratified randomization, with the precise approach depending on the outcome and model.

Kahan and Morris demonstrated that ignoring balancing variables used in stratified blocks or minimization can lead to inappropriate statistical inference, including unnecessarily conservative analyses in relevant settings.

Adjustment for prognostic baseline variables may also improve precision.

For a continuous outcome, an analysis of covariance model might include treatment assignment and baseline achievement. In a multicenter trial, the analysis may additionally account for site according to the prespecified model.

However, including numerous small sites as fixed effects may create difficulties, particularly when some sites contain very few participants or lack observations in one treatment group.

The statistical method should be selected before outcomes are examined and should reflect the randomization design, target estimand, and available information.

Researchers should not decide whether to adjust for stratification variables by testing whether those variables differ significantly between randomized groups at baseline.

Does Stratification Guarantee Better Statistical Power?

Not necessarily. Stratification can improve treatment allocation balance on important prognostic characteristics, but its effect on statistical power depends on the characteristics selected, the allocation restrictions, and the planned analysis.

Stratifying on a weakly prognostic variable may provide little practical benefit.

Conversely, adjustment for a strongly prognostic baseline variable can improve precision even when that variable was not used for stratification.

The advantages of stratification should therefore be evaluated together with the statistical analysis strategy rather than treated as an automatic increase in power.

Can Stratification Introduce New Problems?

Yes. Excessive stratification can produce many sparsely populated categories. Poorly protected allocation sequences can become predictable, particularly when small fixed blocks are used.

Misclassification of baseline characteristics can also undermine the intended balance. If recruiters classify participants inconsistently, the randomization procedure may not operate as planned.

Stratification variables should therefore have clear definitions and reliable measurement procedures.

Another concern arises when researchers select variables after recruitment begins or alter categories in response to observed group composition. Such modifications can compromise the prespecified allocation design.

Any necessary changes should be formally documented, justified, and evaluated for their consequences for trial integrity.

When Is Stratification Unnecessary?

Stratification may be unnecessary when the trial is sufficiently large, unrestricted randomization is acceptable, and no baseline factor provides a compelling reason for design-based balance.

It may also add little value when proposed factors are weakly prognostic, difficult to measure reliably, or divided into categories with very low expected enrollment.

In some circumstances, prespecified covariate adjustment without stratified allocation may adequately address precision concerns.

However, large sample size alone does not prohibit stratification. A large multicenter trial may still benefit from restricted allocation within important sites or prognostic categories.

The choice should follow the trial's scientific and operational needs rather than a rigid sample-size threshold.

Stratifying an Educational Technology Trial by Baseline Achievement

The design improves balance on the selected achievement categories but does not guarantee equality in every participant characteristic or in the continuous baseline scores themselves.

Its scientific value depends on whether achievement is sufficiently prognostic to justify stratification and whether the categories can be applied reliably.

If the study also attempted to stratify by institution, year level, sex, and digital literacy, the number of possible strata could increase substantially. With only 120 participants, many combinations might contain too few students for effective within-stratum blocking.

The simpler design may therefore be preferable, provided the selected factor is justified and the analysis appropriately adjusts for relevant baseline information.

Common Misconceptions About Stratified Randomization

How to Decide Whether Stratification Belongs in Your Trial

Start by identifying baseline characteristics that have a strong and defensible relationship with the primary outcome.

Then determine whether chance imbalance on those characteristics would be sufficiently consequential to justify restricted allocation.

Document the scientific rationale for each factor, category definitions, sequence-generation procedure, within-stratum allocation method, and expected enrollment.

Do not use baseline significance tests after randomization to decide retrospectively which factors should have been stratified.

Finally, ensure that the selected approach is operationally feasible. A theoretically appealing allocation algorithm provides little benefit if participant categories cannot be measured consistently or the procedure cannot be implemented securely.

Before Implementing Stratified Randomization

Questions About When and How to Stratify Randomization

Stratify for Important Prognostic Balance, Not for Every Available Variable

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.